Longitudinal and Transverse Relaxivity Analysis of Native Ferritin and Magnetoferritin at 7 T MRI.
Oliver StrbakLucia BalejcikovaMartina KmetovaJan GombosJozef KovacDusan DobrotaPeter KopcanskyPublished in: International journal of molecular sciences (2021)
Magnetite mineralization in human tissue is associated with various pathological processes, especially neurodegenerative disorders. Ferritin's mineral core is believed to be a precursor of magnetite mineralization. Magnetoferritin (MF) was prepared with different iron loading factors (LFs) as a model system for pathological ferritin to analyze its MRI relaxivity properties compared to those of native ferritin (NF). The results revealed that MF differs statistically significantly from NF, with the same LF, for all studied relaxation parameters at 7 T: r1, r2, r2*, r2/r1, r2*/r1. Distinguishability of MF from NF may be useful in non-invasive MRI diagnosis of pathological processes associated with iron accumulation and magnetite mineralization (e.g., neurodegenerative disorders, cancer, and diseases of the heart, lung and liver). In addition, it was found that MF samples possess very strong correlation and MF's relaxivity is linearly dependent on the LF, and the transverse and longitudinal ratios r2/r1 and r2*/r1 possess complementary information. This is useful in eliminating false-positive hypointensive artefacts and diagnosis of the different stages of pathology. These findings could contribute to the exploitation of MRI techniques in the non-invasive diagnosis of iron-related pathological processes in human tissue.
Keyphrases
- iron deficiency
- contrast enhanced
- magnetic resonance imaging
- signaling pathway
- endothelial cells
- diffusion weighted imaging
- lps induced
- pi k akt
- oxidative stress
- nuclear factor
- induced pluripotent stem cells
- heart failure
- cross sectional
- computed tomography
- magnetic resonance
- squamous cell carcinoma
- papillary thyroid
- inflammatory response
- cell proliferation
- social media
- lymph node metastasis
- childhood cancer